BioNTech SE (ETR:22UA)
Germany flag Germany · Delayed Price · Currency is EUR
101.70
+6.60 (6.94%)
At close: Aug 21, 2026

BioNTech SE Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9,7417,6759,76211,66413,8751,693
Short-Term Investments
3,7236,0656,0824,885189.4381.6
Cash & Short-Term Investments
13,46413,74115,84416,54914,0652,074
Cash Growth
-1.25%-13.28%-4.26%17.66%578.04%53.95%
Accounts Receivable
174.3932.31,4742,1617,14612,382
Other Receivables
70.952.650179.10.40.4
Receivables
245.2984.91,5242,3407,14612,382
Inventory
100.6110.7283.3357.7439.6502.5
Other Current Assets
1,4881,3101,152281.1271.9113.4
Total Current Assets
15,29716,14718,80419,52721,92215,072
Property, Plant & Equipment
1,2181,2911,183971.6821.1520.4
Long-Term Investments
1,8492,4541,2131,17680.221.3
Goodwill
373.3367.9380.6362.561.257.8
Other Intangible Assets
1,4221,606790.4781.7145.4136.8
Long-Term Accounts Receivable
-29.8---
Long-Term Deferred Tax Assets
15.713.581.781.3229.6-
Other Long-Term Assets
167.8107.367.2105.819.622.2
Total Assets
20,34321,98922,53023,00623,27915,831

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
646.7534.9426.7354204.1160
Current Portion of Long-Term Debt
10.87.2---102
Current Portion of Leases
46.44539.528.13627.9
Current Income Taxes Payable
21.265.64.5525.5595.91,569
Current Unearned Revenue
742.5754.9294.9353.377.1186.1
Other Current Liabilities
481.6734.71,758809.62,0381,437
Total Current Liabilities
1,9492,1422,5232,0712,9513,482
Long-Term Debt
102.129.9-2.42.117.9
Long-Term Leases
156.8185.3214.7188.6174.1153.7
Long-Term Unearned Revenue
87.688183398.548.49
Long-Term Deferred Tax Liabilities
33.384.342.439.76.266.7
Other Long-Term Liabilities
256.1234.6155.360.742.1208.2
Total Liabilities
2,5852,7643,1192,7603,2243,937

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
259259248.6248.6248.6246.3
Retained Earnings
16,60917,96219,09819,76318,8339,883
Treasury Stock
-7.8-7.7-8.6-10.8-5.3-3.8
Comprehensive Income & Other
897.11,01173.1244.8979.31,768
Total Common Equity
17,75819,22419,41120,24620,05611,894
Shareholders' Equity
17,75819,22419,41120,24620,05611,894
Total Liabilities & Equity
20,34321,98922,53023,00623,27915,831

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
316.1267.4254.2219.1212.2301.5
Net Cash (Debt)
13,14813,47315,59016,33013,8521,773
Net Cash Growth
-1.62%-13.58%-4.53%17.88%681.38%60.10%
Net Cash Per Share
53.0455.7464.8567.2855.456.83
Filing Date Shares Outstanding
251.2239.97239.97237.73240.99242.52
Total Common Shares Outstanding
251.2251.33239.97237.73243.22242.52
Working Capital
13,34814,00416,28017,45718,97111,591
Book Value Per Share
70.6976.4980.8985.1682.4649.04
Tangible Book Value
15,96317,25018,24019,10219,84911,699
Tangible Book Value Per Share
63.5468.6476.0180.3581.6148.24
Land
-586.4369.4235.4217104.1
Machinery
-491.5427.7344.1273198.3
Construction In Progress
-478.5460.6389.5235.594.3